Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (Unaudited)

v3.24.3
Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Income Statement [Abstract]        
Revenues $ 3,579 $ 2,731 $ 6,970 $ 6,158
Cost of revenues 2,218 1,741 4,303 3,964
Gross profit 1,361 990 2,667 2,194
Operating expenses        
Research and development 506 536 976 861
Selling, general and administrative 1,705 1,662 3,714 3,781
Total operating expenses 2,211 2,198 4,690 4,642
Loss from operations (850) (1,208) (2,023) (2,448)
Other income (expense), net 387 (90) 563 (301)
Loss from operations before income taxes (463) (1,298) (1,460) (2,749)
Income tax expense (147) (186) (293) (153)
Net loss $ (610) $ (1,484) $ (1,753) $ (2,902)
Net loss per share: basic $ (0.59) $ (5.75) $ (1.86) $ (11.47)
Net loss per share: diluted $ (0.59) $ (5.75) $ (1.86) $ (11.47)
Weighted-average number of shares: basic 1,034 258 943 253
Weighted-average number of shares: diluted 1,034 258 943 253
Other comprehensive loss        
Foreign currency translation adjustments $ (593) $ (213) $ (1,474) $ 298
Comprehensive loss $ (1,203) $ (1,697) $ (3,227) $ (2,604)